Cavis

Cavis Technologies is a company that provides the world's first pressure guide wire, called Cavis Wirecath®, which eliminates hydrostatic error. Their goal is to provide simple and accurate measurements for confident decision making in the assessment of coronary artery disease. The Wirecath® is immune to hydrostatic pressure errors and offers fingertip torque response in tortuous vessels. Cavis Technologies aims to reduce stenting and overall costs. They have conducted studies on the impact of hydrostatic pressure variations on fractional flow reserve values in the coronary circulation. With their innovative technology, Cavis Technologies is revolutionizing the measurement of intracardiac pressures.